ÂÜÀòÂÒÂ×

Greg has worked with a variety of early and mid-stage businesses in the areas of financial planning and analysis, investment analysis, and financing. Most recently he served as CFO of ImmunoMolecular Therapeutics, a private clinical stage biotech company. Previously, he has served as CFO of MicroBiome Therapeutics and Accera, both commercial stage biotech companies, closing financings for over $50 million in multiple transactions. Previously to his biotech roles, Greg was a two-time President’s club winner with a predecessor company to CenturyLink while working in a variety of finance positions, ultimately serving as business unit CFO for the company’s Cable TV unit. He has been an adjunct instructor in finance at Metro State University in Denver and Arapahoe Community College. Greg was awarded the Chartered Financial Analyst designation from the CFA Institute. An Iowa native, Greg holds a B.S. in Industrial Engineering from Iowa State University, and an M.B.A. degree from Creighton University.